Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Apr;1(2):e000554.
doi: 10.1161/JAHA.111.000554. Epub 2012 Apr 24.

Cardiovascular pharmacogenomics: current status and future directions-report of a national heart, lung, and blood institute working group

Kiran Musunuru  1 , Dan M Roden, Robin Boineau, Michael R Bristow, Timothy A McCaffrey, Christopher Newton-Cheh, Dina N Paltoo, Yves Rosenberg, Jay G Wohlgemuth, Issam Zineh, Ahmed A K Hasan
Affiliations

Cardiovascular pharmacogenomics: current status and future directions-report of a national heart, lung, and blood institute working group

Kiran Musunuru et al. J Am Heart Assoc. 2012 Apr.
No abstract available

Keywords: genetic polymorphisms; genetics; pharmacogenetics; pharmacogenetics anticoagulants; pharmacogenetics cholesterol.

PubMed Disclaimer

References

    1. Wadelius M, Chen LY, Eriksson N, Bumpstead S, Ghori J, Wadelius C, Bentley D, McGinnis R, Deloukas P. Association of warfarin dose with genes involved in its action and metabolism. Hum Genet. 2007;121:23-34 - PMC - PubMed
    1. Gage BF, Eby C, Johnson JA, Deych E, Rieder MJ, Ridker PM, Milligan PE, Grice G, Lenzini P, Rettie AE, Aquilante CL, Grosso L, Marsh S, Langaee T, Farnett LE, Voora D, Veenstra DL, Glynn RJ, Barrett A, McLeod HL. Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin. Clin Pharmacol Ther. 2008;84:326-331 - PMC - PubMed
    1. International Warfarin Pharmacogenetics Consortium. Klein TE, Altman RB, Eriksson N, Gage BF, Kimmel SE, Lee MT, Limdi NA, Page D, Roden DM, Wagner MJ, Caldwell MD, Johnson JA. Estimation of the warfarin dose with clinical and pharmacogenetic data. N Engl J Med. 2009;360:753-764 - PMC - PubMed
    1. Caldwell MD, Awad T, Johnson JA, Gage BF, Falkowski M, Gardina P, Hubbard J, Turpaz Y, Langaee TY, Eby C, King CR, Brower A, Schmelzer JR, Glurich I, Vidaillet HJ, Yale SH, Qi Zhang K, Berg RL, Burmester JK. CYP4F2 genetic variant alters required warfarin dose. Blood. 2008;111:4106-4112 - PMC - PubMed
    1. Wadelius M, Chen LY, Lindh JD, Eriksson N, Ghori MJ, Bumpstead S, Holm L, McGinnis R, Rane A, Deloukas P. The largest prospective warfarin-treated cohort supports genetic forecasting. Blood. 2009;113:784-792 - PMC - PubMed

LinkOut - more resources